78
Participants
Start Date
April 6, 2020
Primary Completion Date
August 26, 2020
Study Completion Date
August 26, 2020
11-point pain scale
Subjects will be asked to rate their headache pain using an 11-point scale, i.e. on an integer scale from 0 to 10 inclusive, with 0 indicating no pain and 10 indicating the worst pain imaginable.
Headache diary
Subjects will be asked to record specific information for the first (and all subsequent) severe or very severe migraine headaches that they experience while enrolled in the study.
Avulux®
Avulux® device
Sham Avulux®
Sham Avulux®
Endocrinology Research Associates, Inc., Columbus
Remington-Davis Clinical Research, Columbus
Clinical Research Institute, Inc., Minneapolis
Collaborators (1)
Imarc Research, Inc.
INDUSTRY
Avulux, Inc.
INDUSTRY